Impact of depression on patients with Idiopathic Pulmonary Fibrosis

A. Tzouvelekis (Athens, Greece)

Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases

Session: Best clinical practice for the management of chronic lung diseases
Session type: Poster Discussion
Number: 357

Disease area: Interstitial lung diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Tzouvelekis (Athens, Greece). Impact of depression on patients with Idiopathic Pulmonary Fibrosis. 357

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Cognitive impairment and depression in patients with Idiopathic Pulmonary Fibrosis Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias? Year: 2018
Treatment of Idiopathic Pulmonary Fibrosis Source: Guideline 2015 Year: 2015
Association between Pulmonary Infections and the Prognosis in Patients with Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021
Evaluation of Dyspnea Questionnaires in Patients with Idiopathic Pulmonary Fibrosis (IPF). Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018
Platelet activation indices in patients with Idiopathic Pulmonary Fibrosis Source: International Congress 2014 – ILDs 5 Year: 2014
Clinical Correlates of Physical Activity in Idiopathic Pulmonary Fibrosis (IPF) Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019
Is Pulmonary Medication Adherence affected by disease severity among adult patients with Cystic Fibrosis? Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis Year: 2020
Tele-rehabilitation program in Idiopathic Pulmonary Fibrosis Source: International Congress 2019 – M-health/e-health I Year: 2019
Prevalence and Characteristics of Patients Receiving Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020
Impact of specific organic exposure on the prognosis in Idiopathic Pulmonary Fibrosis Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017
Plasma derived-exosome microRNAs in Idiopathic Pulmonary Fibrosis of Anti-synthetase syndrome Disease patients Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021
Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry Source: Eur Respir J , 49 (2) 1601592; DOI: 10.1183/13993003.01592-2016 Year: 2017
IPF - Idiopathic Pulmonary Fibrosis Source: Breathe, 15 (2) 153; 10.1183/20734735.ELF152 Year: 2019
Is Pulmonary Rehabilitation A Savior In Idiopathic Pulmonary Fibrosis? Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis Year: 2020
Treatment of Idiopathic Pulmonary Fibrosis - Executive Summary Source: Guideline 2015 Year: 2015
Quantitative Assessment of Thoracic Muscles in Patients with Idiopathic pulmonary fibrosis :Relationship with Prognosis Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018
Cognitive impairment in patients with Idiopathic Pulmonary Fibrosis - Obstructive Sleep Apnea Overlap Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019
Idiopathic Pulmonary Fibrosis (IPF) Source: ERS Courses: Interstitial Lung Diseases Year: 2019
Idiopathic Pulmonary Fibrosis (IPF) Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2019
Idiopathic Pulmonary Fibrosis (IPF) Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2018